In the complex world of pharmaceutical manufacturing, securing a consistent and high-quality supply of key intermediates is paramount. For companies involved in the production of antiviral therapies, particularly those targeting Hepatitis C, understanding the sourcing of essential building blocks like (2S,4S)-1-(tert-butoxycarbonyl)-4-(methoxymethyl)pyrrolidine-2-carboxylic acid (CAS: 1378388-16-9) is crucial. This article aims to guide pharmaceutical procurement managers and research scientists in identifying reliable manufacturers and suppliers for this vital compound.

The chemical compound (2S,4S)-1-(tert-butoxycarbonyl)-4-(methoxymethyl)pyrrolidine-2-carboxylic acid, identified by CAS number 1378388-16-9, plays a pivotal role as an intermediate in the synthesis of Velpatasvir. Velpatasvir is a highly effective NS5A inhibitor, a cornerstone in modern treatment regimens for Hepatitis C virus (HCV) infection. Its efficacy in combination therapies has made it a widely sought-after pharmaceutical. Consequently, the demand for its precursors, such as our featured intermediate, remains consistently high.

As a dedicated pharmaceutical intermediate supplier, we understand the stringent requirements of the pharmaceutical industry. Our commitment is to provide (2S,4S)-1-(tert-butoxycarbonyl)-4-(methoxymethyl)pyrrolidine-2-carboxylic acid with a guaranteed purity of 97%min. This ensures that researchers and production chemists receive a material that meets their exact specifications, minimizing variability in synthesis and maximizing the yield and purity of the final Active Pharmaceutical Ingredient (API).

When looking to buy (2S,4S)-1-(tert-butoxycarbonyl)-4-(methoxymethyl)pyrrolidine-2-carboxylic acid, it is essential to partner with a manufacturer that prioritizes quality, reliability, and competitive pricing. We leverage our expertise in organic chemistry and our robust supply chain networks, particularly within China, to offer this intermediate at a favourable Velpatasvir intermediate price. Our aim is to support your R&D efforts and bulk manufacturing needs efficiently.

For those seeking to optimize their procurement strategy, consider the following:

  • Verify Purity and Specifications: Always confirm the purity levels and physical characteristics (e.g., appearance as a white solid) meet your project's demands.
  • Assess Supplier Reliability: Choose manufacturers with a proven track record in supplying pharmaceutical intermediates, backed by certifications and consistent quality control.
  • Inquire about Bulk Quantities: If you are planning large-scale production, discuss your volume requirements to secure favorable pricing and ensure continuous supply.
  • Request Samples: Before committing to larger orders, requesting a sample is a prudent step to evaluate the product's quality firsthand.

As a proactive pharmaceutical intermediate manufacturer, we are equipped to handle inquiries for both small research quantities and large commercial volumes. Our team is dedicated to providing comprehensive support, from initial inquiry to delivery. We encourage you to reach out to us for a prompt quote or to discuss how we can best fulfill your requirements for this critical Velpatasvir intermediate. Securing a dependable source for this chiral intermediate is key to accelerating your drug development timelines and ensuring the success of your pharmaceutical endeavors.